Advisor Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Advisor Group’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Sell	25 -10	-29%	-$843	﹤0.01%	5038
2019 Q3	$3K	Sell	35 -14	-29%	-$1.14K	﹤0.01%	4892
2019 Q2	$4K	Hold	49	–	–	﹤0.01%	4797
2019 Q1	$6K	Hold	49	–	–	﹤0.01%	4617
2018 Q4	$4K	Sell	49 -93	-65%	-$8.96K	﹤0.01%	4649
2018 Q3	$14K	Hold	142	–	–	﹤0.01%	4101
2018 Q2	$16K	Sell	142 -105	-43%	-$11.5K	﹤0.01%	3848
2018 Q1	$24K	Sell	247 -112	-31%	-$11.3K	﹤0.01%	3582
2017 Q4	$38K	Buy	359 +42	+13%	+$4.62K	﹤0.01%	3284
2017 Q3	$35K	Sell	317 -175	-36%	-$19K	﹤0.01%	3204
2017 Q2	$55K	Sell	492 -51	-9%	-$5.76K	﹤0.01%	2786
2017 Q1	$63K	Sell	543 -12	-2%	-$1.33K	﹤0.01%	2527
2016 Q4	$58K	Sell	555 -2	-0.4%	-$209	﹤0.01%	2505
2016 Q3	$62K	Hold	557	–	–	﹤0.01%	2352
2016 Q2	$79K	Buy	+557	New	+$79K	﹤0.01%	2098

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Advisor Group's TARO Position: Q4 2019 in Review

Advisor Group reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 29% in Q4 2019, selling an estimated $843 and leaving 25 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5038.

Advisor Group first reported a position in TARO in Q2 2016 and has held it in 15 quarters since. The position peaked at $79K in Q2 2016. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2019.

Advisor Group held 25 shares of Taro Pharmaceutical Industries Ltd. worth $2K as of Q4 2019.
Advisor Group sold 10 Taro Pharmaceutical Industries Ltd. shares in Q4 2019, an estimated $843.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5038 holding.
Advisor Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Taro Pharmaceutical Industries Ltd. position peaked at $79K in Q2 2016.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.